Preoperative Radiochemotherapy in Rectal Cancer: Is There an Impact of Oxaliplatin on Pathologic Complete Response and Survival Rates under “Real World“ Conditions?

This study aimed to evaluate the benefit of additional administration of oxaliplatin during fluorouracil-based neoadjuvant radiochemotherapy (nRCT) in terms of pathologic complete remission (pCR), disease-free survival (DFS), and overall survival (OS) in patients with advanced rectal cancer. Between...

Descripción completa

Detalles Bibliográficos
Autores principales: Grabenbauer, Alexander, Aigner, Thomas, Göbel, Holger, Leibl, Bernhard J., Lamberti, Christof, Grabenbauer, Gerhard G., Distel, Luitpold V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913152/
https://www.ncbi.nlm.nih.gov/pubmed/36766741
http://dx.doi.org/10.3390/cells12030399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913152/
https://www.ncbi.nlm.nih.gov/pubmed/36766741
http://dx.doi.org/10.3390/cells12030399

Ejemplares similares